Fernandez A, Mills E N C, Lovik M, Spoek A, Germini A, Mikalsen A, Wal J M
European Food Safety Authority, Parma, Italy.
Food Chem Toxicol. 2013 Dec;62:1-6. doi: 10.1016/j.fct.2013.08.023. Epub 2013 Aug 16.
Allergenicity assessment of genetically modified (GM) plants is one of the key pillars in the safety assessment process of these products. As part of this evaluation, one of the concerns is to assess that unintended effects (e.g. over-expression of endogenous allergens) relevant for the food safety have not occurred due to the genetic modification. Novel technologies are now available and could be used as complementary and/or alternative methods to those based on human sera for the assessment of endogenous allergenicity. In view of these developments and as a step forward in the allergenicity assessment of GM plants, it is recommended that known endogenous allergens are included in the compositional analysis as additional parameters to be measured.
转基因植物的致敏性评估是这些产品安全性评估过程中的关键支柱之一。作为该评估的一部分,一个关注点是评估由于基因改造而未出现与食品安全相关的非预期效应(例如内源性过敏原的过度表达)。现在有了新技术,可作为基于人血清的方法的补充和/或替代方法,用于评估内源性致敏性。鉴于这些进展,并作为转基因植物致敏性评估向前迈出的一步,建议在成分分析中纳入已知的内源性过敏原作为要测量的额外参数。